期刊文献+

不同病理分型脑胶质瘤切除患者Th17/Treg相关细胞因子及其与术后颅内感染的关系 被引量:1

Th17/Treg related cytokines in patients with different pathological stages of glioma and their relationship with postoperative intracranial infection
原文传递
导出
摘要 目的检测不同病理分型脑胶质瘤切除患者辅助性T细胞17/调节性T细胞(Th17/Treg)平衡及相关细胞因子水平,分析与术后颅内感染的关系。方法选择2017年3月-2021年2月南阳市第二人民医院收治的87例脑胶质瘤患者作为研究对象,根据胶质瘤病理检查结果将患者分为低级别组(WHOⅠ~Ⅱ级,59例)及高级别组(WHOⅢ~Ⅳ级,28例);统计胶质瘤患者术后感染情况,采用流式细胞仪检测外周血Th17、Treg细胞水平,计算Th17/Treg;采用酶联免疫吸附法检测转化生长因子-β1(TGF-β1)、白细胞介素-6(IL-6)、IL-17水平,比较不同级别胶质瘤患者感染情况及各指标水平情况。结果高级别组患者Th17、Treg、TGF-β1、IL-6、IL-17高于低级别组(P<0.05);低级别组胶质瘤患者颅内感染发生率为5.08%(3/59)低于高级别组(P<0.05);低级别及高级别组患者中,感染患者Th17/Treg、TGF-β1、IL-6、IL-17均高于非感染患者(P<0.05);Logistic多因素分析示,高级别胶质瘤是颅内感染的危险因素(P<0.05)。结论高级别脑胶质瘤患者Th17/Treg平衡失衡及炎症因子水平异常现象高于低级别脑胶质瘤患者,这一变化可能是高级别脑胶质瘤患者感染风险较高的机制。 OBJECTIVE To detect the balance of T helper 17 cells/regulatory T cells(Th17/Treg)and related cytokines in patients with different pathological stages of gliomas,and to analyze their relationship with postoperative intracranial infection.METHODS A total of 87 patients with gliomas admitted to Nanyang Second People's Hospital between Mar.2017 and Feb.2021 were selected as the study subjects,and the patients were divided into low-grade group(WHO grade Ⅰ-Ⅱ,59 cases)and high-grade group(WHO gradsⅢ-Ⅳ,28 cases)according to the pathological results.The postoperative infections of glioma patients were counted,and the levels of peripheral blood Th17 and Treg cells were detected by flow cytometry,and Th17/Treg was calculated.The levels of transforming growth factor-β1(TGF-β1),interleukin-6(IL-6)and interleukin-17(IL-17)were measured by enzyme-linked immunosorbent assay,and the infection status and levels of each index in patients with different grades of glioma were compared.RESULTS Th17,Treg,TGF-β1,IL-6,and IL-17 in the high-grade group were higher than those in the low-grade group(P<0.05).The incidence of intracranial infection in the low-grade group was 5.08%(3/59),lower than that in the high-grade group(P<0.05).Among patients with low-grade and high-grade gliomas,Th17/Treg,TGF-β1,IL-6,and IL-17 in the infected patients were higher than those in the uninfected patients(P<0.05).Multivariate logistic analysis showed that high-grade glioma was an independent risk factor for intracranial infection(P<0.05).CONCLUSION The imbalance of Th17/Treg and abnormal levels of inflammatory factors were higher in patients with high-grade gliomas than in patients with low-grade gliomas,which might be a mechanism for the higher risk of infection in patients with high-grade gliomas.
作者 蔡春雨 李琳 酒晓盈 李晓彬 王玲玲 郑奕 訾东燕 周保丹 CAI Chun-yu;LI Lin;JIU Xiao-ying;LI Xiao-bin;WANG Ling-ling;ZHENG Yi;ZI Dong-yan;ZHOU Bao-dan(Nanyang Second People's Hospital,Nanyang,Henan 473000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2023年第11期1646-1649,共4页 Chinese Journal of Nosocomiology
基金 河南省医学科技攻关联合共建基金资助项目(LHGJ20191471)。
关键词 胶质瘤切除术 术后感染 病理分级 T淋巴细胞区群 调节性T细胞 Glioma Postoperative infection Pathological stage T lymphocyte Regulatory T cell
  • 相关文献

参考文献9

二级参考文献35

  • 1Ostrom QT, Gitfleman H, Liao P, et al. CBTRUS statis- tical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011 [ J ]. Neuro Oncol, 2014, 16( Suppl 4) : iv1-iv63.
  • 2Rolle CE, Sengupta S, Lesniak MS. Challenges in clini- cal design of immunotherapy trials for malignant glioma [J]. Neurosurg Clin N Am, 2010, 21(1): 201-214.
  • 3Galea I, Bernardes-Silva M, Forse PA, et al. An antigen- specific pathway for CD8 T cells across the blood-brain barrier[J]. J Exp Med, 2007, 204(9) : 2023-2030.
  • 4Harrington LE, Hatton RD, Mangan PR, et al. Interleu- kin 17-producing CD4 + effector T cells develop via a lin- eage distinct from the T helper typel and 2 lineages [ J ] Nat Irnmunol, 2005, 6 (11): 1123-1132.
  • 5Ivanov II, McKenzie BS, Zhou L, et al. The orphan nu- clear receptor RORgammat directs the differentiation pro- gram of proinflammatory IL-17 + T helper cells [ J]. Cell, 2006, 126(6) : 1121-1133.
  • 6Trifari S, Kaplan CD, Tran EH, et al. Identification of a human helper T cell population that has abundant produc- Lion of interleukin 22 and is distinct from T (H)-17, T (H)I and T(H)2 cells[J]. Nat Immunol, 2009, 10( 8 ) : 864-871.
  • 7Duhen T, Geiger R, Jarrossay D, et al. Production of in- terleukin 22 but not intedeukin 17 by a subset of human skin-homing memory T cells [ J]. Nat Immunol, 2009, 10(8) : 857-863.
  • 8Muranski P, Boni A, Antony PA, et al. Tumor-specific Th17-polarized cells eradicate large established melanoma [J]. Blood, 2008, 112(2) : 362-373.
  • 9Wang L, Yi T, Kortylewski M, et al. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway [J]. J Exp Med, 2009, 206(7) : 1457-1464.
  • 10Wainwright DA, Sengupta S, Han Y, et al. The pres- ence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma [ J ]. PLoS One, 2010, 5 (10): e15390.

共引文献5857

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部